EMA Backs First Drug for Severe Overgrowth Disorders

The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening PIK3CA-related overgrowth disorders.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/ema-backs-first-drug-severe-overgrowth-disorders-2026a1000gsu?src=rss

Author :

Publish date : 2026-05-22 14:46:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

EMA Backs First Drug for Severe Overgrowth Disorders

EMA Backs Breast Cancer SERD After FDA No Vote

Creeping Gradients After TAVR Linked to Poor Longer-Term Outcomes

Related Posts

Blood Markers to Direct Lung Cancer Screening; Name Change for PCOS

I’ve Seen One Too Many E-Scooter Injuries in the Trauma Bay

A Look at Major Ebola Outbreaks and When the Disease Was First Identified

Why Perimenopause Is an Ideal Time for Prevention

Excessive social media ‘negatively impacts wellbeing’

From decades to years – AI could speed search for brain drugs hiding in plain sight

Blood Markers to Direct Lung Cancer Screening; Name Change for PCOS

I’ve Seen One Too Many E-Scooter Injuries in the Trauma Bay

A Look at Major Ebola Outbreaks and When the Disease Was First Identified

Why Perimenopause Is an Ideal Time for Prevention

Excessive social media ‘negatively impacts wellbeing’

From decades to years – AI could speed search for brain drugs hiding in plain sight

Migraine With Aura Tied to Higher Stroke Risk

Higher Caffeine Intake Tied to Greater Depression Severity

Categories

Archives